European Patent Office: Patentees remain in control

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

European Patent Office: Patentees remain in control

In appeal proceedings before the EPO, patentees and applicants frequently withdraw failed requests at the end of oral proceedings. For example, if the patentee's second auxiliary request is allowed, whereas the main and first auxiliary requests are rejected, most patentees will routinely withdraw the main and first auxiliary requests. Such withdrawal may in particular be made with a view to expediting the Board of Appeals' subsequent preparation of the written decision, as no written reasoning is to be prepared in respect of withdrawn requests.

In proceedings pertaining to EPO decision T 1477/15 dated February 23 2017 (made available online on July 26 2017), the Board was prompted to consider the allowability of such withdrawal of requests. The patentee's main requests as well as the first and second auxiliary requests had been rejected during the course of the oral proceedings, whereas the third auxiliary request had succeeded. The second auxiliary request corresponded to the request held allowable by the first-instance department in the decision under appeal. At the end of the oral proceedings in appeal, the patentee withdrew the first and second auxiliary requests. The opponents took the view that they had a right to a substantiated decision on their successful appeal against the impugned decision, so the patentee had no right to withdraw the request.

Referring to Article 113(2) EPC, according to which the EPO can only decide on the text submitted by the applicant or patentee, the Board, however, held that there was no basis in the European Patent Convention for not allowing the patentee to withdraw the contested requests. The Board further noted that "it is generally accepted that in appeal proceedings the principle of party disposition applies, meaning that parties can put forward, withhold or withdraw their requests as they see fit". The Board therefore had no power to object to the patentee's withdrawal of the first and second auxiliary requests.

Applicants and patentees are thus reassured that they remain in control of the requests that will eventually be scrutinised in the appeal boards' written decisions.

frederiksen.jpg

Jakob Pade Frederiksen



Inspicos P/S

Kogle Allé 2

DK-2970 Hoersholm

Copenhagen, Denmark

Tel: +45 7070 2422

Fax: +45 7070 2423

info@inspicos.com

www.inspicos.com

more from across site and SHARED ros bottom lb

More from across our site

Erise IP has added a seven-practitioner trademark team from Hovey Williams, signalling its intention to help clients at all stages of development
News of prison sentences for ex-Samsung executives for trade secrets violation and an opposition filed by Taylor Swift were also among the top talking points
A multijurisdictional claim filed by InterDigital and a new spin-off firm in Germany were also among the top talking points
Duarte Lima, MD of Spruson & Ferguson’s Asia practice, says practitioners must adapt to process changes within IP systems, as well as be mindful of the implications of tech on their practices
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
DWF helped client Dairy UK secure a major victory at the UK Supreme Court
Hepworth Browne led Emotional Perception AI to victory at the UK Supreme Court, which rejected a previous appellate decision that said an AI network was not patentable
James Hill, general counsel at Norwich City FC, reveals how he balances fan engagement with brand enforcement, and when he calls on IP firms for advice
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Gift this article